As of April 24, 2025, Embecta (EMBC) has a market cap of $0.65 billion USD. According to our data, Embecta is ranked No.5664 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 24, 2025 | $0.65 B |
-45.57%
|
Dec 31, 2024 | $1.20 B |
13.56%
|
Dec 29, 2023 | $1.06 B |
-23.11%
|
Dec 30, 2022 | $1.37 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Medtronic
MDT
|
$106.93 B |
0.001 M
|
![]() Ireland
|
![]() Abbott Laboratories
ABT
|
$224.14 B |
-0.002 M
|
![]() USA
|
![]() DexCom
DXCM
|
$26.22 B |
-0.001 M
|
![]() USA
|
![]() Insulet
PODD
|
$17.31 B |
-0.001 M
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$273.04 B |
66.814 B
|
![]() Denmark
|
![]() Eli Lilly
LLY
|
$744.81 B |
0.006 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$374.44 B |
0.003 M
|
![]() USA
|
![]() Stryker Corporation
SYK
|
$132.87 B |
-0.002 M
|
![]() USA
|
![]() Becton Dickinson
BDX
|
$58.09 B |
0.001 M
|
![]() USA
|
![]() Tandem Diabetes Care
TNDM
|
$1.10 B |
-0.000 M
|
![]() USA
|
![]() Edwards Lifesciences
EW
|
$41.27 B |
-0.002 M
|
![]() USA
|
![]() Boston Scientific
BSX
|
$140.59 B |
-0.004 M
|
![]() USA
|
![]() Zimmer Biomet
ZBH
|
$19.68 B |
-0.001 M
|
![]() USA
|
Market Cap | = | EMBC Stock Price | * | EMBC Shares Outstanding |
= | $11.24 | * | 58.13 M | |
= | $0.65 B |